REGENXBIO Inc.RGNXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank75
5Y CAGR-2.8%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
-2.8%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
202528.02%
202423.12%
20234.13%
2022-276.85%
2021266.44%
202032.23%
2019-230.70%
2018240.24%
2017-14.89%
2016-146.16%